EHC (STOCKS)
Encompass Health Corporation Common Stock
$101.470000
-0.910000 (-0.89%)
Prev close: $102.380000
Company Information
- Exchange
- XNYS
- Sector
- Health Services
- Industry
- Medical/Nursing Services
- CEO
- Mark J. Tarr
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $10,060.28M
- Employees
- 29,198
- P/E (TTM)
- 16.94
- P/B (TTM)
- 4.00
- Dividend Yield
- 72.93%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $6.07B |
| Benefits Costs and Expenses | $5.06B |
| Costs And Expenses | $4.98B |
| Operating Expenses | $4.98B |
| Operating Income/Loss | $1.09B |
| Income/Loss Before Equity Method Investments | $999.30M |
| Income/Loss From Continuing Operations After Tax | $795.40M |
| Income/Loss From Continuing Operations Before Tax | $1.00B |
| Income/Loss From Discontinued Operations Net Of Tax | $15.40M |
| Income/Loss From Equity Method Investments | $3.80M |
| Income Tax Expense/Benefit | $207.70M |
| Income Tax Expense/Benefit, Deferred | $22.00M |
| Net Income/Loss | $810.80M |
| Net Income/Loss Attributable To Noncontrolling Interest | $201.60M |
| Net Income/Loss Attributable To Nonredeemable Noncontrolling Interest | $191.90M |
| Net Income/Loss Attributable To Parent | $609.20M |
| Net Income/Loss Attributable To Redeemable Noncontrolling Interest | $9.70M |
| Net Income/Loss Available To Common Stockholders, Basic | $607.60M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $1.60M |
| Preferred Stock Dividends And Other Adjustments | $1.60M |
| Basic Earnings Per Share | $6.08 |
| Diluted Earnings Per Share | $5.99 |
| Basic Average Shares | 300,300,000 |
| Diluted Average Shares | 305,100,000 |
| Assets | $7.31B |
| Current Assets | $1.03B |
| Accounts Receivable | $676.00M |
| Other Current Assets | $353.10M |
| Noncurrent Assets | $6.28B |
| Intangible Assets | $300.30M |
| Other Non-current Assets | $5.98B |
| Liabilities | $3.95B |
| Current Liabilities | $876.80M |
| Accounts Payable | $204.00M |
| Other Current Liabilities | $672.80M |
| Noncurrent Liabilities | $3.07B |
| Redeemable Noncontrolling Interest | $58.80M |
| Equity | $3.31B |
| Equity Attributable To Noncontrolling Interest | $786.70M |
| Equity Attributable To Parent | $2.52B |
| Temporary Equity | $58.80M |
| Liabilities And Equity | $7.31B |
| Net Cash Flow From Operating Activities | $1.22B |
| Net Cash Flow From Operating Activities, Continuing | $1.20B |
| Net Cash Flow From Operating Activities, Discontinued | $20.50M |
| Net Cash Flow From Investing Activities | -$756.20M |
| Net Cash Flow From Investing Activities, Continuing | -$756.20M |
| Net Cash Flow From Financing Activities | -$403.30M |
| Net Cash Flow From Financing Activities, Continuing | -$403.30M |
| Net Cash Flow | $61.10M |
| Net Cash Flow, Continuing | $40.60M |
| Net Cash Flow, Discontinued | $20.50M |
| Comprehensive Income/Loss | $810.60M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $201.60M |
| Comprehensive Income/Loss Attributable To Parent | $609.00M |
| Other Comprehensive Income/Loss | -$200.00K |